Physical and neuropsychological development of children with Citrin deficiency

Ni-Si Zhang1, Zhan-Hui Zhang, Wei-Xia Lin1

  • 1Department of Pediatrics, The First Affiliated Hospital of Jinan University, Guangzhou 510630, China.

Insights

Children with Citrin deficiency (CD) often experience physical and neuropsychological developmental delays. Regular assessments are crucial for monitoring growth and development in these children.

Area of Science:

  • Pediatrics
  • Medical Genetics
  • Developmental Biology

Background:

  • Citrin deficiency (CD) is a genetic disorder affecting the SLC25A13 gene.
  • Early identification and monitoring of developmental milestones are essential for children with CD.

Purpose of the Study:

  • To investigate the physical and neuropsychological development in children diagnosed with Citrin deficiency.
  • To determine the incidence rates of various developmental delays in this cohort.

Main Methods:

  • Retrospective analysis of 93 children diagnosed with CD via SLC25A13 gene analysis.
  • Inclusion of 100 cases, considering assessments before and after one year of age.
  • Evaluation of birth conditions, physical growth, and neuropsychological development indices.

Main Results:

  • 25% of children exhibited failure to thrive, and 47% were small for gestational age.
  • Incidence rates included growth retardation (23%), underweight (14%), and microcephalus (9%).
  • 25% of cases showed neuropsychological developmental delay, with gross motor (15%) and language (9%) delays being most common.

Conclusions:

  • Citrin deficiency is associated with significant physical and neuropsychological developmental delays in children.
  • Routine monitoring of physical growth and neurodevelopment is recommended for early intervention in CD patients.
Abstract

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
416
Information Processing Approach01:30

Information Processing Approach

The information-processing theory of cognitive development centers on fundamental mental processes, including attention, memory, and problem-solving skills. Researchers in this field examine how cognitive abilities, such as working memory, evolve and influence children's overall development. Studies indicate that children with stronger working memory tend to excel in reading comprehension, math, and problem-solving compared to peers with less efficient memory skills. Low working memory is...
209
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
24
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
299
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
15
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.0K